RxDoctor Payments Data

David McKenna, PA

Physician Assistant · Seneca, SCNPI 1215538913

Payments from drug & device makers

$804in general payments, 2019–2025

Across 46 payments — averaging $17.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$198
  • AbbVie$148
  • Lilly USA, LLC$73
  • Novo Nordisk$54
  • Pfizer$46
  • Xeris Pharmaceuticals, Inc.$42
  • plus $244 from 10 others

What the payments were for

  • Food & beverage$804100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$804 in reported general payments places this provider in the 60th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$62,115
Medicare patients
156
Services billed
4,326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide105$113,647
FarxigaDapagliflozin Propanediol130$100,173
Trelegy ElliptaFluticasone/Umeclidin/Vilanter126$86,471
MounjaroTirzepatide60$64,284
EliquisApixaban56$47,955
RybelsusSemaglutide33$47,577
JardianceEmpagliflozin33$33,047
VraylarCariprazine Hcl14$24,494
Repatha SureclickEvolocumab36$21,375
LinzessLinaclotide20$20,174
EntrestoSacubitril/Valsartan17$16,173
TrulicityDulaglutide16$15,046
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$13,547
Tresiba Flextouch U-100Insulin Degludec12$6,501
Albuterol Sulfate HfaAlbuterol Sulfate169$4,304

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$54$161,223138 claims
AstraZenecaFarxiga, Breztri Aerosphere$198$113,720148 claims
GSKTrelegy Ellipta$33$86,471126 claims
Lilly USA, LLCMounjaro, Trulicity$73$79,33076 claims
PfizerEliquis$46$47,95556 claims
AbbVieVraylar, Linzess, Synthroid$148$46,03254 claims
NovartisEntresto$41$16,17317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Seneca

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →